Showing posts with label MHRA. Show all posts
Showing posts with label MHRA. Show all posts

Wednesday, June 23, 2010

MHRA Press Release: £150,000 Fake Drug Stash Seized in Sting Operation


MHRA, the United Kingdom’s agency responsible medicines and medical devices work, released a press announcement regarding a large seizure of counterfeit, unlicensed medicines and controlled drugs in London on June 9th.


The following is the Press Release from MHRA:


Counterfeit and unlicensed medicines, along with controlled drugs to the street value of approximately £150,000, were seized by the MHRA yesterday as part of a simultaneous raid on six locations across London, and two in Yorkshire with the assistance of local police.


Six people in the UK believed to be linked to a gang in Asia were arrested in connection with the illegal sale and supply of a range of medicinal products, most of which are suspected to be counterfeit.


Information was initially passed to the MHRA by pharmaceutical manufacturers Pfizer, Lilly and Sanofi-Aventis.


MHRA Head of Intelligence Nimo Ahmed said, “Large boxes containing counterfeit and unlicensed medicines together with packaging, computers and cash were seized and the suspect medicines will now be sent to government laboratories to assess their authenticity.


“The products seized relate to treatment for depression, erectile dysfunction, as well as painkillers, sedatives and injectable anabolic steroids.


“At this stage it is suspected that these medicines would have been supplied illegally over the internet.”

Mr. Ahmed said people should be vigilant when buying medicines online and should only do so from registered websites that clearly display a contact name, number, the logo from the Royal Pharmaceutical Society of Great Britain (RPSGB), and from premises that are registered with the RPSGB. Buying medicines from unregistered websites is dangerous as people would not know what they are actually taking. The dosages could be either too high or too low, or worse, the tablet could contain harmful ingredients.


“Better still, the safest way to obtain Prescription Only Medicines is from a ‘bricks and mortar’ pharmacy following a consultation with a GP or a healthcare professional,” he said.


“Those involved in this type of criminality do not care about your health. They are only in it for one reason, and that is to make money.”

The MHRA are grateful for the assistance provided by the Metropolitan Police, West Yorkshire Police, South Yorkshire Police and the pharmaceutical manufacturers in this case.

This seizure is an excellent example of the continued proliferation of counterfeit medications within developed countries and sophisticated pharmaceutical supply chains. Since 2006 the MHRA has seized more than £6 million worth of counterfeit medicines.


Secure Pharma Chain Blog endorses continued regulation and enforcement related to fraudulent, adulterated and counterfeit medications and encourages all within the supply chain, including regulatory agencies to deploy solutions and technologies to protect their inventories and consumers from the deadly effects of this criminal act.


To read the entire Press Release on the MHRA website, visit: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON084731.


To learn more about anti-counterfeiting technologies, visit: www.xstreamsystems.net.

Sunday, December 27, 2009

UK Gets Tough with Bogus Drug Website Operators

Those operating bogus online pharmacies could face stiffer penalties, up to 12 years jail time under a new law developed by Britain’s Medical and Healthcare Products Regulatory Agency (MHRA).

Specific criminal sentences for counterfeiting medicines are to be introduced in the UK. Convicted individuals would face a maximum penalty of 10-12 years' imprisonment, the agency has announced. Individuals could be found guilty of either supplying or offering to supply counterfeit medicines.

Stronger enforcement is in answer to the increase of counterfeit medicines in the United Kingdom. Earlier this year a British newspaper survey indicated that one out of four general practitioners believes they have treated a victim of counterfeit drugs.

To view the entire article visit: http://www.healthcarerepublic.com/news/975201/Bogus-drug-website-operators-face-12-year-jail-sentences/.

Tuesday, November 10, 2009

Fake Meds Lure 7 M Adults in UK - But it could cost them more than just a charge on their credit card!

Pfizer shocked the world early this year when they release anti-counterfeiting campaign in the theaters in the United Kingdom. They are now continuing this campaign for public awareness with posters and commercials on TV. Due to their graphic nature, the commercial was only shown after 11 p.m.

The main message is an elaboration of “Buyer Beware” – especially when it comes to online purchases of medications. In an age where consumers are buying more of their products online, they need to be cautious when it comes to medications.

New research indicating the scale of the counterfeit medicine culture was released last week as part of this hard-hitting campaign to educate the public of the risks involved in purchasing fake medicines from unregulated websites. The Get Real, Get A Prescription public awareness campaign is being launched in a partnership between Pfizer, the Medicines and Healthcare products Regulatory Agency (MHRA), the Royal Pharmaceutical Society of Great Britain (RPSGB), The Patients Association and HEART UK.

More than one in seven British Adults survey (15%) admitted to bypassing the healthcare system to get medication without a prescription. That would equate to around 7 million adults who are gambling with their lives. So why would consumers take this risk? - A majority (60%) of adults agree that they're more trusting of all purchases they make online today compared to five years ago. About one fifth stated they believe offering medications online at discounted pricing is a public service and about a third believe the medication to be true. But 78% of General Practitioners believe this practice puts their patient’s health and potentially their lives at risk, due to the prevalence of counterfeit drugs online.

David Pruce from the Royal Pharmaceutical Society of Great Britain said: "Pharmacists are very concerned about the increase in fake or counterfeit medicines. As expert professionals in medicines and medicines use, we know only too well that fake medication does not work and that it can cause harm. Stay safe by ensuring that you always get your prescriptions dispensed at a registered UK pharmacy. If you want to buy medicines online, always check that you are dealing with a genuine pharmacy. Don't go on face value - some of the illegal sites look very professional but supply dangerous fakes. Check our website for a list of sites that have been awarded the RPSGB's internet pharmacy logo so that you can be sure that you are dealing with a UK registered pharmacy supplying genuine medicines. This campaign is important. We want the UK to be the safest place to obtain medicines."

Consumers can go to http://www.realdanger.co.uk for more information and advice.

To read entire article visit: http://www.medicalnewstoday.com.

Monday, July 6, 2009

UK Recalls Multiple Generic Drugs

Violations of European standards by an outsourced Indian manufacturer have prompted the recall of multiple generic drugs in the United Kingdom.

Novartis's generics unit was one of about eight companies that recalled drugs this week because of "serious" deficiencies in so-called good manufacturing practices found during inspections of the contract manufacturer, MJ Biopharm, in India, according to the U.K. Medicines and Healthcare Products Regulatory Agency.

Novartis generic unit, Sandoz recalled fluoxetine, an antidepressant which is the generic version of Eli Lilly’s Prozac. Other drugs recalled by Sandoz included Baclofen for muscle spasms, and metformin for diabetes.

Other recalled drugs included hypertension pills amlodipine and doxazosin and pain-reliever naproxen. The other companies that recalled drugs included Strandhaven Ltd., LPC Medical Ltd., Karib Kemi Pharm Ltd., Milpharm Ltd., Greystone Ltd., Jubilant Pharmaceuticals NV and Wockhardt UK Ltd.

To view the entire article visit the Wall Street Journal Online at: www.wsj.com.

Tuesday, June 9, 2009

UK: Online Dealer of Fake Medicines is Jailed

The Medicines and Healthcare products Regulatory Agency (MHRA) reported that a 49-year-old unlicensed and counterfeit medicines dealer has been sentenced to two years imprisonment at Southwark Crown Court. Mr. Martin Simon Hickman pleaded guilty to six counts of selling and supplying fake and unlicensed medicines, and money laundering to the sum of £1.4m.

Mr. Hickman operated an illegal online pharmacy and sold over £6m worth of fake Viagra and unlicensed Kamagra and Lovegra (Indian erectile dysfunction drugs) in the United Kingdom and abroad between 2003 to 2007.

His illegal gains funded a lavish lifestyle - a £2.5million riverside apartment in Chelsea, West London, property in the Spanish millionaires’ resort of Marbella and a four-bedroom farmhouse.

MHRA Head of Enforcement, Mick Deats, said the man enjoyed a lavish lifestyle on the profits made by selling the unlicensed and fake drugs. "People dealing in these types of businesses are criminals, but at the much higher end of the pay scale," he said. "Mr Hickman has substantially benefitted financially from this unlawful trade."

"He is not a healthcare professional, in fact, he is not professional in any way shape or form. He is simply a money motivated criminal living a life of luxury at the expense of other people's health."

MHRA investigation began in 2005 and ran till his site was successfully closed in 2007. Because the website was hosted in Germany the MHRA had to take out an injunction to shut the website down. But Hickman still continued to trade and in 2007 was jailed for three months for ignoring the injunction.

Hickman also had prior dealings in illegal pharmaceuticals and in 1998 he was jailed for 10 months for conspiracy to trade in steroids.

Friday, April 17, 2009

One in Four British Doctors has Treated Victims of Counterfeit Drugs

A story in the British News site, Daily Mail, portrays the danger of purchasing prescriptions online. An estimated 2 million Britons regularly buy medicines, including prescription drugs and those not available on the NHS, over the internet for a range of conditions.

In the GP Newspaper Poll, 25% of the doctors surveyed said they had treated patients for adverse reactions resulting from medicines purchased online. What’s more an additional 8% felt they would be treating such a case in the future.

General Practitioners are calling for stricter regulations to ensure the safety of their patients. Over 85% of them want stricter laws because as they state - a majority of the individuals behind the sites have no professional qualifications to administer medications.

Dr Sarah Jarvis, a GP in west London and spokesman for the Royal College of GPs, said: "Surveys looking at many online medications suggest that the proportion of counterfeits is enormously high and that many of them contain very worrying ingredients."

The UK drug safety watchdog, the Medicines and Healthcare products Regulatory Agency (MHRA), has also been running a campaign warning about fake medicines. A spokesman said: 'Anyone who self-medicates and buys their medicines from internet sites could be in danger of receiving counterfeit or substandard medicines. At best these will be a waste of money, at worst they can kill.

Tuesday, April 7, 2009

UK Associations Supporting MHRA Requirements to Combat Drug Counterfeits

Medical News Today reported that several prominent pharmacy associations within the UK are supporting proposals for the MHRA to strengthen the pharmaceutical supply chain and reduce the risk from counterfeit medications.

This endorsement, seemingly unprecedented within the US and EU, is another telltale sign that the impact of fake and counterfeit medications within this highly regulated and developed nation has reached a point where significant measures need to be in place to protect the pharmaceutical supply and its consumers. Hopefully other pharmacy organizations within the US and EU will follow suit to protect their populations.

Read the story below:

Pharmacy Bodies Response To Reducing The Risk From Counterfeit Medicine

(March 26, 2009) The Association of Independent Multiples (AIMp), Community Pharmacy Wales (CPW), Company Chemists Association (CCA), The National Pharmacy Association (NPA) and The Pharmaceutical Services Negotiating Committee (PSNC) have responded to the MHRA consultation on measures to strengthen the medicines supply chain and reduce the risk from counterfeit medicines.

The pharmacy bodies support the proposals for the MHRA to strengthen the requirements for holding a Wholesalers dealer licence (WDL) and also the new proposals for Responsible Persons with the establishment of a Code of Conduct against which Responsible Persons can be judged. The MHRA should also have the power to remove a Responsible Person from the register. The bodies also support the introduction of a due diligence obligation for the holder of a WDL.

Whilst supporting the proposals to ensuring that potential offences relating to counterfeit medicines are provided for in legislation the bodies oppose the introduction of an offence for failing to report a suspect counterfeit medicine. A criminal sanction is inappropriate for failure to report.

To view the article visit www.medicalnewstoday.com

Tuesday, March 31, 2009

Government Agencies Guiding Pharmacists to Dispense Information on Counterfeit Drugs

Counterfeit drugs within the mainstream supply chain have become so prevalent that the Royal Pharmaceutical Society of Great Britain (RPSGB) and the Medicines and Healthcare Products Regulatory Agency (MHRA), leading regulatory agencies within the United Kingdom, are guiding pharmacists to distribute information on the dangers of counterfeit drugs with the prescriptions that they dispense to all of their patients.

This is a cautionary story for all developed countries, including the United States that the issue of counterfeit medications invading its safe and ethical supply channels is coming your way.

Until now many, including leading pharmaceutical industry experts, have considered it remote that a developed country could and would be infiltrated by the scourge of counterfeit medications.

Patients to get counterfeit warning with each prescription
Tuesday , March 31, 2009

New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB and MHRA.

Pharmacies nationwide will receive the guidance, which has been developed in conjunction with patient groups to ensure it is clear and easy to read. Pharmacies will be asked to distribute the new double-sided postcard-sized leaflet to patients in their prescription bags.

The leaflet offers advice to patients about what counterfeit medicine are, how to minimise purchasing fakes and what to do if they suspect they have been sold or supplied counterfeits.

One side of the postcard explains the safest way to purchase medicines and the other outlines 'The dangers of faking it'.

The RPSGB's head of practice Heidi Wright says: "Counterfeit medicine does not work and can make you seriously ill. It's important that people are aware that they should always get their medicine from a reputable source such as a pharmacist or a registered online pharmacy site which has the RPSGB's Internet Pharmacy Logo - and I hope these postcards will help to achieve that."

The MHRA is also looking at ways to target those that use the internet to buy counterfeit medicine.

Guidance for pharmacists explains the background to counterfeit medicine production and highlights how organised criminal gangs have become involved in the production of illegal medicines, supplying them through the internet, often to unwitting patients.

It offers pharmacists invaluable practical advice on the correct steps to take when they encounter suspected counterfeit medicines. These steps include reporting illegal websites to the MHRA to ensure immediate patient safety.

pharmafocus.com

Monday, March 9, 2009

BBC: Seized Drugs 'Were Counterfeit'


The following story about a major counterfeit drug raid in the UK was posted on the BBC Online. This story illustrates how pervasive and relatively common counterfeit and fraudulent medications are becoming within communities and everyday life within developed countries:

More than £250,000 of counterfeit, unlicensed and withdrawn medicines have been seized during raids in Stoke-on-Trent, the drug regulatory agency said.

A woman aged 50 was bailed on suspicion of illegally selling prescription drugs after the morning raids on Tuesday, March 3rd.

The Medicines and Healthcare products Regulatory Agency (MHRA) said a couple in their 60s was being questioned.

It said the drugs were the "tip of the iceberg" of an expected multi-million-pound illegal online medicine business.

For the full story follow this link:
http://news.bbc.co.uk/go/em/fr/-/2/hi/uk_news/england/staffordshire/7924072.stm